FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072000804> ?p ?o ?g. }

• W2072000804 endingPage "38" @default.
• W2072000804 startingPage "29" @default.
• W2072000804 abstract "The Vectra platform (Caliper Life Sciences, Hopkinton, MA) is an advanced multispectral imaging system for biomarker quantitation in tissue microarray or intact tissue sections. This is the first study to validate its reliability for quantitating spatially overlapping biomarkers using chromogenic multiplexed immunohistochemistry on prostate tissue microarrays. Two tissue microarray cohorts (an outcome tissue microarray and a progression tissue microarray) were used. The outcome tissue microarray cohort consists of 462 duplicate cores with more than 5-year outcome information. The progression tissue microarray cohort consists of 384 duplicate cores from different disease (stage) groups. The tissue microarray slides were stained with different combinations of antibodies (anti-androgen receptor, anti-E-cadherin, anti-erythroblastosis virus E26 oncogene-related gene product, and anti-α-methylacyl-CoA racemase). Three outcome tissue microarrays were stained with androgen receptor + erythroblastosis virus E26 oncogene-related gene + E-cadherin (outcome tissue microarray 1), androgen receptor + E-cadherin (outcome tissue microarray 2), and erythroblastosis virus E26 oncogene-related gene + E-cadherin (outcome tissue microarray 3), respectively. One progression tissue microarray section was stained with E-cadherin and α-methylacyl-CoA racemase; tissue microarray slides were then scanned with the Vectra platform. Biomarker expression analysis was performed with Vectra software-Nuance 3.0.0, and inForm 1.2. IBM SPSS Statistics 19 was used for statistical and correlation analysis (SPSS, Chicago, IL). Close concordance was found between the triple- and double-immunostaining assays used for quantitating spatially overlapping biomarkers androgen receptor and erythroblastosis virus E26 oncogene-related gene using outcome tissue microarrays (r = 0.897 for androgen receptor and 0.613 for erythroblastosis virus E26 oncogene-related gene, respectively). α-Methylacyl-CoA racemase and E-cadherin expression levels measured in progression tissue microarray were consistent with previously published data by other groups. In conclusion, Vectra technology is reliable for objective and high-throughput biomarker quantitation and colocalization study using chromogenic multiplexed immunohistochemistry." @default.
• W2072000804 created "2016-06-24" @default.
• W2072000804 creator A5012753093 @default.
• W2072000804 creator A5014356411 @default.
• W2072000804 creator A5014529996 @default.
• W2072000804 date "2013-01-01" @default.
• W2072000804 modified "2023-10-01" @default.
• W2072000804 title "A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays" @default.
• W2072000804 cites W1935682792 @default.
• W2072000804 cites W1935960420 @default.
• W2072000804 cites W1978740715 @default.
• W2072000804 cites W1983663948 @default.
• W2072000804 cites W1989790390 @default.
• W2072000804 cites W1995156882 @default.
• W2072000804 cites W2003955264 @default.
• W2072000804 cites W2009081609 @default.
• W2072000804 cites W2018560195 @default.
• W2072000804 cites W2022904488 @default.
• W2072000804 cites W2030694663 @default.
• W2072000804 cites W2035936829 @default.
• W2072000804 cites W2036004730 @default.
• W2072000804 cites W2044093030 @default.
• W2072000804 cites W2044495234 @default.
• W2072000804 cites W2045778975 @default.
• W2072000804 cites W2057044825 @default.
• W2072000804 cites W2070263748 @default.
• W2072000804 cites W2077038168 @default.
• W2072000804 cites W2089561494 @default.
• W2072000804 cites W2113530051 @default.
• W2072000804 cites W2114965121 @default.
• W2072000804 cites W2121158863 @default.
• W2072000804 cites W2136665987 @default.
• W2072000804 cites W2146191095 @default.
• W2072000804 cites W2150391295 @default.
• W2072000804 cites W2152178820 @default.
• W2072000804 cites W4250006491 @default.
• W2072000804 cites W4254591891 @default.
• W2072000804 doi "https://doi.org/10.1016/j.humpath.2012.05.009" @default.
• W2072000804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22944297" @default.
• W2072000804 hasPublicationYear "2013" @default.
• W2072000804 type Work @default.
• W2072000804 sameAs 2072000804 @default.
• W2072000804 citedByCount "132" @default.
• W2072000804 countsByYear W20720008042013 @default.
• W2072000804 countsByYear W20720008042014 @default.
• W2072000804 countsByYear W20720008042015 @default.
• W2072000804 countsByYear W20720008042016 @default.
• W2072000804 countsByYear W20720008042017 @default.
• W2072000804 countsByYear W20720008042018 @default.
• W2072000804 countsByYear W20720008042019 @default.
• W2072000804 countsByYear W20720008042020 @default.
• W2072000804 countsByYear W20720008042021 @default.
• W2072000804 countsByYear W20720008042022 @default.
• W2072000804 countsByYear W20720008042023 @default.
• W2072000804 crossrefType "journal-article" @default.
• W2072000804 hasAuthorship W2072000804A5012753093 @default.
• W2072000804 hasAuthorship W2072000804A5014356411 @default.
• W2072000804 hasAuthorship W2072000804A5014529996 @default.
• W2072000804 hasConcept C104317684 @default.
• W2072000804 hasConcept C121608353 @default.
• W2072000804 hasConcept C142724271 @default.
• W2072000804 hasConcept C150194340 @default.
• W2072000804 hasConcept C186836561 @default.
• W2072000804 hasConcept C193270364 @default.
• W2072000804 hasConcept C204232928 @default.
• W2072000804 hasConcept C2776235491 @default.
• W2072000804 hasConcept C2780192828 @default.
• W2072000804 hasConcept C2781197716 @default.
• W2072000804 hasConcept C54355233 @default.
• W2072000804 hasConcept C61367390 @default.
• W2072000804 hasConcept C71924100 @default.
• W2072000804 hasConcept C8415881 @default.
• W2072000804 hasConcept C86803240 @default.
• W2072000804 hasConceptScore W2072000804C104317684 @default.
• W2072000804 hasConceptScore W2072000804C121608353 @default.
• W2072000804 hasConceptScore W2072000804C142724271 @default.
• W2072000804 hasConceptScore W2072000804C150194340 @default.
• W2072000804 hasConceptScore W2072000804C186836561 @default.
• W2072000804 hasConceptScore W2072000804C193270364 @default.
• W2072000804 hasConceptScore W2072000804C204232928 @default.
• W2072000804 hasConceptScore W2072000804C2776235491 @default.
• W2072000804 hasConceptScore W2072000804C2780192828 @default.
• W2072000804 hasConceptScore W2072000804C2781197716 @default.
• W2072000804 hasConceptScore W2072000804C54355233 @default.
• W2072000804 hasConceptScore W2072000804C61367390 @default.
• W2072000804 hasConceptScore W2072000804C71924100 @default.
• W2072000804 hasConceptScore W2072000804C8415881 @default.
• W2072000804 hasConceptScore W2072000804C86803240 @default.
• W2072000804 hasIssue "1" @default.
• W2072000804 hasLocation W20720008041 @default.
• W2072000804 hasLocation W20720008042 @default.
• W2072000804 hasOpenAccess W2072000804 @default.
• W2072000804 hasPrimaryLocation W20720008041 @default.
• W2072000804 hasRelatedWork W1973815231 @default.
• W2072000804 hasRelatedWork W2047657429 @default.
• W2072000804 hasRelatedWork W2056361639 @default.
• W2072000804 hasRelatedWork W2082810093 @default.
• W2072000804 hasRelatedWork W2096388990 @default.

• next